MDM2 gene SNP309 | ||||
---|---|---|---|---|
event-free survival | overall survival | |||
G/G vs. G/T and T/T | T/T vs. G/T and G/G | G/G vs. G/T and T/T | T/T vs. G/T and G/G | |
DLBC samples | 1.20 (0.71;2.01) | 0.95 (0.61;1.48) | 1.19 (0.65;2.18) | 0.81 (0.48;1.38) |
all samples: | 0.98 (0.63;1.52) | 1.21 (0.86;1.72) | 0.98 (0.59;1.64) | 0.99 (0.66;1.48) |
relative risk with 95% confidence interval | ||||
p53 gene SNP72 | ||||
event-free survival | overall survival | |||
Arg/Arg vs. Arg/Pro and Pro/Pro | Pro/Pro vs. Arg/Pro and Arg/Arg | Arg/Arg vs. Arg/Pro and Pro/Pro | Pro/Pro vs. Arg/Pro and Arg/Arg | |
DLBC samples | 1.06 (0.69;1.65) | 1.31 (0.40;4.30) | 1.13 (0.68;1.88) | 1.60 (0.37;6.90) |
all samples: | 0.93 (0.66;1.31) | 1.45 (0.63;3.30) | 0.99 (0.66;1.47) | 1.41 (0.51;3.87) |
relative risk with 95% confidence interval |